← Back to Markets

IBO

Impact Biomedical Inc · NYSE MKT LLC · Pharmaceuticals

$0.67+$0.03 (+4.59%)

Prices delayed up to 5 minutes

AC Intelligence

AC Intelligence

AC Intelligence for IBO is being prepared.

Key Stats

Key Stats

Open

$0.61

Day High

$0.69

Day Low

$0.59

Prev Close

$0.64

Volume

0

Avg Volume

247.5K

Day Change

+$0.03

Change %

+4.59%

Fundamentals

Fundamentals

P/B

3.92

EPS (TTM)

$-3.58

Market Cap

$70M

52-Wk Range

$0.36 — $1.95

Earnings History

Insider Activity

Who Owns This Stock

Who Owns IBO

Passive / Index79.8%3 holders
Tactical / Macro9.6%1 holder
Other9.0%12 holders
Dealer / Bank1.6%7 holders

Based on Q4 2025 13F filings + AC behavioral model

24 institutional holders

Top Holders

1.Vanguard Group
+538.0%$258.9B
2.Vanguard Group
+236.0%$136.3B
3.BlackRock, Inc.
$131.3B
4.Point72
$69.6B
5.Geode Capital Management
+46.6%$31.7B
6.TWO SIGMA INVESTMENTS, LP
$20.1B
7.Vanguard Group
-59.9%$16.3B
8.TWO SIGMA SECURITIES, LLC
$11.5B
$8.3B
10.JANE STREET GROUP, LLC
$7.1B
11.State Street
$6.0B
12.Geode Capital Management
-72.9%$5.9B
13.Northern Trust Corp
$5.2B
14.Mason & Associates Inc
0.0%$5.0B
15.Morgan Stanley IM
$4.6B
16.UBS Group AG
0.0%$1.1B
17.Tower Research Capital LLC (TRC)
$720M
18.Bank of America Corp
+782.2%$450M
19.Wells Fargo & Company
0.0%$113M
0.0%$43M

Institutional Pressure

Market Regime:Strong Risk-Off (-0.62)
SELLINGBUYING
Mild Selling Pressure
Passive / Index(79.8%)
Holds
Tactical / Macro(9.6%)
Reducing rapidly
Other(9.0%)
Dealer / Bank(1.6%)
Facilitating
Systematic / Quant(0.0%)
De-risking (mechanical)

80% passive + quality floor won't sell.

Updated daily · Based on Q4 2025 filings + AC behavioral model

Sentiment Signals

Sentiment Signals

Insider ActivityNo insider transactions in last 90 daysSEC Form 4
↑↑Inst. Flows20 increased/new, 4 decreased/exited (13F)AC 13F Analysis

Sources: SEC Form 4, AC 13F Analysis

On AcidCapitalist

On AcidCapitalist

No recent mentions of IBO on AcidCapitalist.

Data provided by Finnhub. Prices delayed up to 5 minutes.